Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
- Chamber
- Senate
- Introduced
- Apr 9, 2025
- Last action
- Jun 13, 2025 — COMMITTED TO RULES
- Session
- 2025-2026
- Momentum
- 59 · Moderate